BIO Asia–Taiwan 2021 亞洲生技大會

BIO Asia–Taiwan 2021 亞洲生技大會

講師

Chung-hsiun Wu

Session 7 – Public Private Partnership for Precision Health

Date:22 July (Thursday)
Time:  12:20 – 13:50 (GMT+8)

Chung-hsiun Wu

President
​Development Center for Biotechnology

Dr. Wu has been the President of Development Center for Biotechnology since 2018. He is the Chairman of Taiwan BIO since 2020 October.  He is an entrepreneur and an expert in biologics, including recom­binant proteins, vaccines, and therapeutic antibodies. He was an associate professor of the Institute of Molecular Medicine, National Taiwan University in 1995 - 2000. In 2000, he co-founded AbGenomics Corp., a biotech company specialized in developing therapeutic antibodies. Over the past 20 years, he produced over 30 publications in peer-reviewed scientific journals and 8 international patents, of which all were licensed-out for commercial applica­tion. Dr. Wu received his Ph.D. from University of Maryland and was a Jane-Coffin-Childs Memorial Fund Fellow in the Department of Embryology, Carnegie Institution of Washington.

Speech title & Synopsis

Expanding International Biomedical Business of Precision Health with Taiwan

Precision health draws public attention around the globe. In this presentation, we would like to touch upon its overview, the latest happenings and relevant capabilities in Taiwan, followed by case studies to provide an insight into associated innovations, including health and medicine management systems, AI-based medical imaging software, smart detection kits and AI + VR technology to speed up drug development. This talk will be wrapped up with an introduction of local potential partners in the field.
 
The President Tsai’s government proactively and heavily invests in Taiwan’s biomedical sector and announced six core strategic industries back in 2020, where precision health becomes one of the major development focuses. With continued and tremendous full support from the government, the future of this emerging industry is promising. All the government ministries and agencies will work together toward further progress.
 
With our world renowned ICT, we are hoping for many more cutting-edge technologies, devices and systems to be developed and applied to the next-generation healthcare in years to come, for instance, telemedicine, telecare, tele-education. To conclude, integrating strong ICT with biological big data, pharmaceuticals, and medical devices, Taiwan is working toward precision health.